Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024
Medifast (NYSE: MED), the health and wellness company behind the OPTAVIA® lifestyle solution, has announced it will release its third quarter 2024 financial results on Monday, November 4, 2024, after market close. The company will host a conference call at 4:30 p.m. ET on the same day to discuss the results.
Key participants in the call will include Dan Chard, Chairman and CEO, and Jim Maloney, CFO. The call will be broadcast live on Medifast's Investor Relations website and archived for access until February 4, 2025. Telephone access is available by dialing (201) 389-0879, with a playback option available from 8:30 p.m. ET, November 4, through November 11, 2024, using access code 13749320.
Medifast (NYSE: MED), la società di salute e benessere dietro la soluzione di stile di vita OPTAVIA®, ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 lunedì 4 novembre 2024, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica alle 16:30 ET nello stesso giorno per discutere i risultati.
I principali partecipanti alla chiamata includeranno Dan Chard, Presidente e CEO, e Jim Maloney, CFO. La chiamata sarà trasmessa in diretta sul sito web delle Relazioni con gli Investitori di Medifast e sarà archiviata per l'accesso fino al 4 febbraio 2025. L'accesso telefonico è disponibile componendo il numero (201) 389-0879, con un'opzione di riproduzione disponibile dalle 20:30 ET, 4 novembre, fino all'11 novembre 2024, utilizzando il codice di accesso 13749320.
Medifast (NYSE: MED), la empresa de salud y bienestar detrás de la solución de estilo de vida OPTAVIA®, ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el lunes 4 de noviembre de 2024, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica a las 4:30 p.m. ET el mismo día para discutir los resultados.
Los participantes clave en la llamada incluirán a Dan Chard, Presidente y CEO, y Jim Maloney, CFO. La llamada será transmitida en vivo en el sitio web de Relaciones con Inversores de Medifast y estará archivada para su acceso hasta el 4 de febrero de 2025. Se puede acceder por teléfono marcando el (201) 389-0879, con una opción de reproducción disponible desde las 8:30 p.m. ET, el 4 de noviembre, hasta el 11 de noviembre de 2024, utilizando el código de acceso 13749320.
메디패스트 (NYSE: MED), OPTAVIA® 라이프스타일 솔루션의 건강 및 웰니스 회사가 2024년 3분기 재무 결과를 2024년 11월 4일 월요일에 시장 마감 후 발표한다고 발표했습니다. 회사는 같은 날 오후 4시 30분 ET에 결과에 대해 논의하는 전화 회의를 개최할 것입니다.
전화 회의의 주요 참가자로는 댄 차드 회장 겸 CEO와 짐 말로니 CFO가 포함됩니다. 회의는 메디패스트의 투자자 관계 웹사이트에서 실시간으로 방송되며, 2025년 2월 4일까지 아카이브되어 접근할 수 있습니다. 전화 접속은 (201) 389-0879로 전화하여 사용할 수 있으며, 11월 4일 오후 8시 30분 ET부터 2024년 11월 11일까지 재생 옵션을 사용할 수 있습니다. 접속 코드 13749320을 사용하세요.
Medifast (NYSE: MED), l'entreprise de santé et de bien-être derrière la solution de style de vie OPTAVIA®, a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le lundi 4 novembre 2024, après la clôture du marché. L'entreprise organisera une conférence téléphonique à 16h30 ET le même jour pour discuter des résultats.
Les principaux participants à l'appel incluront Dan Chard, Président et CEO, et Jim Maloney, CFO. L'appel sera diffusé en direct sur le site Web des relations investisseurs de Medifast et archivé pour un accès jusqu'au 4 février 2025. L'accès téléphonique est disponible en composant le (201) 389-0879, avec une option de lecture disponible du 4 novembre à 20h30 ET jusqu'au 11 novembre 2024, en utilisant le code d'accès 13749320.
Medifast (NYSE: MED), das Gesundheits- und Wellnessunternehmen hinter der OPTAVIA® Lebensstil-Lösung, hat angekündigt, dass es seine Finanzergebnisse für das dritte Quartal 2024 am Montag, den 4. November 2024, nach Börsenschluss veröffentlichen wird. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Wichtige Teilnehmer des Anrufs sind Dan Chard, Vorsitzender und CEO, und Jim Maloney, CFO. Der Anruf wird live auf der Website für Investorenbeziehungen von Medifast übertragen und bis zum 4. Februar 2025 archiviert. Telefonischer Zugang ist möglich unter (201) 389-0879, mit einer Wiedergabeoption von 20:30 Uhr ET, dem 4. November, bis zum 11. November 2024, unter Verwendung des Zugangscodes 13749320.
- None.
- None.
The conference call is scheduled to begin at 4:30 p.m. ET on November 4, 2024. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https://viavid.webcasts.com/starthere.jsp?ei=1691825&tp_key=981ddaa9cf and will be archived online and available through February 4, 2025. To join via telephone, listeners may dial (201) 389-0879.
A telephonic playback will be available from 8:30 p.m. ET, November 4, 2024, through November 11, 2024. Participants can dial (412) 317-6671 and enter access code 13749320 to hear the playback.
About Medifast®
Medifast (NYSE: MED) is the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, which provides people with a simple yet comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA's holistic solution includes lifestyle plans with clinically proven health benefits, scientifically developed products, and a framework for habit creation – all reinforced by independent coach support for customers on their weight loss journeys. Through its collaboration with national virtual primary care provider LifeMD® (Nasdaq: LFMD) and its affiliated medical group, the holistic solution now includes access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature™. Visit the OPTAVIA and Medifast websites for more information and follow Medifast on X and LinkedIn.
MED-F
View source version on businesswire.com: https://www.businesswire.com/news/home/20241021465919/en/
Investor Contact:
Medifast, Inc.
Steven Zenker
InvestorRelations@medifastinc.com
(443) 379-5256
Source: Medifast
FAQ
When will Medifast (MED) release its Q3 2024 financial results?
What time is Medifast's (MED) Q3 2024 earnings conference call?
How can I access Medifast's (MED) Q3 2024 earnings call?
Who will be participating in Medifast's (MED) Q3 2024 earnings call?
